Management to Hold Investor Day Conference Call Today at 10:00am ETReported record product revenue of $11.6 million in Q4 2024, an increase of ...
ETON PHARMACEUTICALS ($ETON) posted quarterly earnings results on Tuesday, March 18th. The company reported earnings of -$0.02 per share, missing estimates of -$0.00 ...
5d
Company’s patented desmopressin oral solution successfully passed pivotal bioequivalence study -- Company expects to submit New Drug ...
DEER PARK, Ill. - Eton Pharmaceuticals, Inc. (NASDAQ:ETON), a $377 million market cap pharmaceutical company whose stock has surged over 227% in the past year, has announced the successful ...
Eton is an innovative pharmaceutical company focused on developing ... For more information, please visit our website at www.etonpharma.com. Forward-Looking Statements Statements contained in this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results